Literature DB >> 34976372

Statins Show Promise Against Progression of Liver Disease.

Prashanth Francis1, Lisa M Forman1.   

Abstract

Content available: Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 34976372      PMCID： PMC8688902          DOI： 10.1002/cld.1143

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  82 in total

1.  Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.

Authors:  Arpan Mohanty; Janet P Tate; Guadalupe Garcia-Tsao
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

Review 2.  Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.

Authors:  Theodore Lytras; Georgios Nikolopoulos; Stefanos Bonovas
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

3.  Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Case-control Study.

Authors:  Margarita N German; Megan K Lutz; Perry J Pickhardt; Richard J Bruce; Adnan Said
Journal:  J Clin Gastroenterol       Date:  2020-09       Impact factor: 3.062

4.  STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?

Authors:  Juan G Abraldes; Kelly W Burak
Journal:  Hepatology       Date:  2016-04-15       Impact factor: 17.425

Review 5.  Managing the Symptoms and Complications of Cholestasis.

Authors:  Mark R Pedersen; Marlyn J Mayo
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-04-04

Review 6.  The current evidence on statin use and prostate cancer prevention: are we there yet?

Authors:  Mahmoud A Alfaqih; Emma H Allott; Robert J Hamilton; Michael R Freeman; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2016-10-25       Impact factor: 14.432

7.  Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.

Authors:  Saptarshi Bishnu; Sk M Ahammed; Avik Sarkar; Jabaranjan Hembram; Saswata Chatterjee; Kshaunish Das; Gopal K Dhali; Abhijit Chowdhury; Kausik Das
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-01       Impact factor: 2.566

8.  KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.

Authors:  Giusi Marrone; Raquel Maeso-Díaz; Guillermo García-Cardena; Juan G Abraldes; Juan Carlos García-Pagán; Jaime Bosch; Jordi Gracia-Sancho
Journal:  Gut       Date:  2014-12-10       Impact factor: 23.059

9.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

Authors:  Naveed Sattar; David Preiss; Heather M Murray; Paul Welsh; Brendan M Buckley; Anton J M de Craen; Sreenivasa Rao Kondapally Seshasai; John J McMurray; Dilys J Freeman; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G Westendorp; James Shepherd; Barry R Davis; Sara L Pressel; Roberto Marchioli; Rosa Maria Marfisi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; John Kjekshus; Terje R Pedersen; Thomas J Cook; Antonio M Gotto; Michael B Clearfield; John R Downs; Haruo Nakamura; Yasuo Ohashi; Kyoichi Mizuno; Kausik K Ray; Ian Ford
Journal:  Lancet       Date:  2010-02-16       Impact factor: 79.321

10.  Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis.

Authors:  Aurora Marina Loaeza-Del Castillo; Alhely Gaytán-Santillán; Alma López-Tello; Merit Valdés-Almanza Merit; María Del Pilar Milke-García; Jorge Flores-Rodríguez; Ulices Alvirde-García
Journal:  Ann Hepatol       Date:  2019-08-22       Impact factor: 2.400
View more
  2 in total

Review 1.  Discovery of farnesoid X receptor and its role in bile acid metabolism.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Mol Cell Endocrinol       Date:  2022-03-11       Impact factor: 4.369

2.  Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats.

Authors:  Kanika Verma; Shikha Makwana; Sarvesh Paliwal; Vartika Paliwal; Smita Jain; Swati Paliwal; Swapnil Sharma
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.